Key Capital Corporation (KCPC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: Oct 29, 2025
Key Capital Revenue
Key Capital had revenue of $500.00K in the quarter ending September 30, 2014. This brings the company's revenue in the last twelve months to $500.00K.
Revenue (ttm)
500.00K
Revenue Growth
n/a
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
46.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 1998 | 25.34M | 4.39M | 20.98% |
| Dec 31, 1997 | 20.94M | 956.88K | 4.79% |
| Dec 31, 1996 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 1995 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medley Management | 33.25M |
| Phoenix Rising Companies | 17.27M |
| Detwiler Fenton Group | 15.20M |
| Legion Capital | 8.34M |
| Fomo Worldwide | 2.10M |
| Global Vision Holdings | 438.18K |
| Champion Investments | 800.00 |
| Green Street Capital | 7.00 |
Key Capital News
- 5 years ago - Key Capital Offers to Help India COVID Crisis with Major Aid Potential via its 24/7 Immune Supplement - Accesswire
- 5 years ago - Key Capital HAP-V+ Immune Supplement Reported Effective Against COVID-19, and Colds and Flu - Accesswire
- 5 years ago - Key Capital Launches Unique Natural Mental Health Supplement - MaxCellLife MIND - Accesswire
- 5 years ago - Key Capital Launches MaxCellLife.com to Market Unique Supplement and Skincare Products - Accesswire
- 5 years ago - Key Capital to Focus on Oral Pill Cancer Treatment Success - Accesswire
- 5 years ago - Key Capital Leads Oral Pill Vaccines Race with Immunitor Partnering and Strong Patenting - Accesswire
- 5 years ago - Key Capital COVID-19 Oral Pill Vaccine Records 90% Reduction in Virus Infectivity in Early Study - Accesswire
- 5 years ago - Key Capital Advises Urgent Global Need For COVID-19 Oral Pill Therapeutic Vaccine - Accesswire